Patents by Inventor Kouichi Ozaki

Kouichi Ozaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8158351
    Abstract: It is an object of the present invention to provide a method for determining inflammatory diseases including myocardial infarction as a typical example, which involves identifying polymorphisms associated with myocardial infarction and using the gene polymorphisms, an oligonucleotide that can be used for the method, a kit for diagnosing inflammatory diseases, a therapeutic agent for inflammatory diseases, and the like. The present invention provides a method for determining an inflammatory disease, which comprises detecting at least one type of gene polymorphism existing in a proteasome subunit ? type 6 gene.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: April 17, 2012
    Assignee: Riken
    Inventors: Toshihiro Tanaka, Yusuke Nakamura, Aritoshi Iida, Kouichi Ozaki, Masatsugu Hori
  • Patent number: 7990033
    Abstract: A display device having a surface with light-emitting regions and non-light-emitting regions, wherein the aforementioned light-emitting regions and non-light-emitting regions are subjected to simultaneous surface treatment selected from: (1) brush treatment; (2) blast treatment; or (3) combined brush and blast treatment, whereby after the aforementioned treatment the surfaces of the light-emitting regions have a 60°-mirror-surface glossiness according to JIS Z 8741 exceeding 20%, while the surfaces of the non-light-emitting regions have a 60°-mirror-surface glossiness according to JIS Z 8741 not exceeding 20%, has good visibility of images reproduced by the display, which is especially suitable for outdoor application.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: August 2, 2011
    Assignee: Dow Corning Toray Company, Ltd.
    Inventors: Toshiki Nakata, Toshio Saruyama, Toyohiko Fujisawa, Toru Imaizumi, Kouichi Ozaki, Takaki Aoyama
  • Publication number: 20110129826
    Abstract: It is an object of the present invention to identify a novel single nucleotide polymorphism (SNP) associated with the development and advancement of inflammatory diseases such as myocardial infarction. The present invention provides a method for judging inflammatory diseases, which comprises detecting at least one gene polymorphism in the BRCA1-associated protein (BRAP) gene.
    Type: Application
    Filed: October 29, 2008
    Publication date: June 2, 2011
    Applicant: RIKEN
    Inventors: Toshihiro Tanaka, Kouichi Ozaki
  • Publication number: 20100233684
    Abstract: It is an object of the present invention to provide a method for determining inflammatory diseases including myocardial infarction as a typical example, which involves identifying polymorphisms associated with myocardial infarction and using the gene polymorphisms, an oligonucleotide that can be used for the method, a kit for diagnosing inflammatory diseases, a therapeutic agent for inflammatory diseases, and the like. The present invention provides a method for determining an inflammatory disease, which comprises detecting at least one type of gene polymorphism existing in a proteasome subunit ? type 6 gene.
    Type: Application
    Filed: June 15, 2007
    Publication date: September 16, 2010
    Applicant: RIKEN
    Inventors: Toshihiro Tanaka, Yusuke Nakamura, Aritoshi Iida, Kouichi Ozaki, Masatsugu Hori
  • Publication number: 20100148649
    Abstract: A display device having a surface with light-emitting regions and non-light-emitting regions, wherein the aforementioned light-emitting regions and non-light-emitting regions are subjected to simultaneous surface treatment selected from: (1) brush treatment; (2) blast treatment; or (3) combined brush and blast treatment, whereby after the aforementioned treatment the surfaces of the light-emitting regions have a 60°-mirror-surface glossiness according to JIS Z 8741 exceeding 20%, while the surfaces of the non-light-emitting regions have a 60°-mirror-surface glossiness according to JIS Z 8741 not exceeding 20%, has good visibility of images reproduced by the display, which is especially suitable for outdoor application.
    Type: Application
    Filed: June 6, 2007
    Publication date: June 17, 2010
    Inventors: Toshiki Nakata, Toshio Saruyama, Toyohiko Fujisawa, Toru Imaizumi, Kouichi Ozaki, Takaki Aoyama
  • Publication number: 20080262157
    Abstract: A curable organopolysiloxane composition comprising: (A) an organopolysiloxane having an average of at least 1.5 alkenyl groups per molecule; (B) an organopolysiloxane having an average of at least 1.5 silicon-bonded hydrogen atoms per molecule; (C) a hydrosilylation-reaction catalyst; and (D) microscopic particles of thermoplastic resin, said particles comprising a thermoplastic resin and at least one type of an organometallic compound selected from the group consisting of organotitanium compound, organozirconium compound, organoaluminum compound, and organotin compound, said organometallic compound being either admixed or encapsulated with said thermoplastic resin, allows obtaining of a cured body not subject to decrease in hardness with the lapse of time during storage of the composition, and forms cured body exhibiting excellent adhesion to various substrates by heating.
    Type: Application
    Filed: June 7, 2005
    Publication date: October 23, 2008
    Applicant: DOW CORNING TORAY COMPANY, LTD.
    Inventors: Toshiki Nakata, Masayuki Onishi, Kouichi Ozaki
  • Publication number: 20070190528
    Abstract: An object of the present invention is to identify a novel single nucleotide polymorphism (SNP) associated with the onset and development of inflammatory diseases such as myocardial infarction. The present invention provides a method for judging inflammatory diseases which comprises detecting at least one gene polymorphism in the galectin-2 gene.
    Type: Application
    Filed: August 18, 2004
    Publication date: August 16, 2007
    Applicants: RIKEN
    Inventors: Toshihiro Tanaka, Yozo Ohnishi, Kouichi Ozaki, Aritoshi Iida, Masatsugu Hori, Yusuke Nakamura
  • Patent number: 6822083
    Abstract: The invention provides a pancreas-specific gene comprising a base sequence coding for the amino acid sequence shown under SEQ ID NO:1, which gene is effective particularly in the fields of study, diagnosis and treatment, among others, of pancreatic carcinoma.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: November 23, 2004
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Yosuke Harada, Kouichi Ozaki
  • Publication number: 20020151025
    Abstract: This invention provides the TSC403 gene having a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:1, which is a novel gene of great utility particularly in the field of research, diagnosis, therapy, etc. for cancer of the lung, among other diseases.
    Type: Application
    Filed: April 5, 2002
    Publication date: October 17, 2002
    Inventors: Masami Nagata, Kouichi Ozaki, Yoshikazu Shimada, Masato Horie
  • Patent number: 6403785
    Abstract: This invention provides the TSC403 gene having a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:1, which is a novel gene of great utility particularly in the field of research, diagnosis, therapy, etc. for cancer of the lung, among other diseases. In addition, this invention provides the human ING1L gene comprising a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:4, which is a novel human gene useful for regulating the cell cycle, inhibiting or activating cell proliferation, studies on metabolic aging or apoptosis of cells, pathological exploration, diagnosis and therapy of cancer and other diseases, and screening for the development of new drugs.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: June 11, 2002
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Masami Nagata, Kouichi Ozaki, Yoshikazu Shimada, Masato Horie
  • Patent number: 6117933
    Abstract: A silicone rubber particulate composition useful as an additive for cosmetics, rubbers, resins and paints is disclosed, said composition comprising:(A) a silicone rubber particulate having an average particle size of 0.1 to 1,000 .mu.m;(B) a water-absorptive resin particulate having a water-free average particle size of 0.1 to 1,000 .mu.m; and(C) water,wherein said component (B) is present at a level of 0.01 to 5 weight percent measured on a water-free basis relative to component (A) and said water is present at a level of 10 to 10,000 weight parts for each 100 weight parts of component (B).
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: September 12, 2000
    Assignee: Dow Corning Toray Silicone Co., Ltd.
    Inventors: Kouichi Ozaki, Norio Matsuda, Makoto Tanoue, Toyohiko Yamadera, Mitsuo Hamada
  • Patent number: 5973060
    Abstract: A silicone rubber particulate composition useful as an additive for cosmetics, rubbers, resins and paints is disclosed, said composition comprising:(A) a silicone rubber particulate having an average particle size of 0.1 to 1,000 .mu.m;(B) a water-absorptive resin particulate having a water-free average particle size of 0.1 to 1,000 .mu.m; and(C) water,wherein said component (B) is present at a level of 0.01 to 5 weight percent measured on a water-free basis relative to component (A) and said water is present at a level of 10 to 10,000 weight parts for each 100 weight parts of component (B).
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: October 26, 1999
    Assignee: Dow Corning Toray Silicone Co., Ltd.
    Inventors: Kouichi Ozaki, Norio Matsuda, Makoto Tanoue, Toyohiko Yamadera, Mitsuo Hamada
  • Patent number: 5808030
    Abstract: An isolated hTFIIIA gene having a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:1, as disclosed, and in particular the hTFIIIA gene having the nucleotide sequence of SEQ ID NO:2. The gene can be used to express a corresponding hTFIIIA protein. The gene and protein serve as transcription regulating factors, and are useful in the diagnosis or identification of hereditary disease, such as cancer or other diseases resulting from abnormal transcriptional control and, further, in analyzing the mechanisms of action thereof.
    Type: Grant
    Filed: September 5, 1995
    Date of Patent: September 15, 1998
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Tsutomu Fujiwara, Satoshi Takeda, Yoshikazu Shimada, Kouichi Ozaki, Sadahito Shin, deceased
  • Patent number: 5601490
    Abstract: A track racing game machine Includes two or more vehicles having a drive motor and a pair of first and second contact members; a looped running track provided with a running lane along which the vehicles move; a power generator for generating a power of a specified level to be supplied to each vehicle to control the speed of the vehicle; and a plurality of pairs of supplying lines provided on the running lane of the running track to supply the power generated by the power generator to the corresponding vehicles, each pair consisting of first and second supplying lines, the first and second supplying lines being in contact with the first and second contact members of the corresponding vehicle, respectively.
    Type: Grant
    Filed: August 23, 1994
    Date of Patent: February 11, 1997
    Assignee: Konami Co., Ltd.
    Inventors: Toshiaki Nakagawa, Hiroshi Yokota, Kouichi Ozaki, Kiyoshi Furukawa